{"entity":{"type":"insider","cik":"0001551965","url":"/insider/0001551965","json_url":"/insider/0001551965.json","name":"Aggarwal Gaurav","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2012-08-02","last":"2022-01-31","span_basis":"filed_date"},"name_variants":[{"name":"Aggarwal Gaurav","source":"filing","n_filings":4,"first_seen":"2012-08-02","last_seen":"2022-01-31"}],"transactions":[{"id":6446848,"accession":"0001209191-22-005748","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-005748","line_url":"/filing/0001209191-22-005748#line-1","is_derivative":false,"issuer_cik":"0001290149","issuer_name":"Sierra Oncology, Inc.","issuer_ticker":"SRRA","issuer_name_source":null,"issuer_url":"/issuer/0001290149","owner_cik":"0001551965","owner_name":"Aggarwal Gaurav","owner_url":"/insider/0001551965","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800000.0,"shares_display":"800,000","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":21600000.0,"total_display":"21,600,000.00","shares_owned_after":2735853.0,"shares_owned_after_display":"2,735,853","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-31","filed_date":"2022-01-31","scope":"insider"},{"id":3094975,"accession":"0001274644-16-000092","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001274644-16-000092","line_url":"/filing/0001274644-16-000092#line-1","is_derivative":false,"issuer_cik":"0001274644","issuer_name":"Ocera Therapeutics, Inc.","issuer_ticker":"OCRX","issuer_name_source":null,"issuer_url":"/issuer/0001274644","owner_cik":"0001551965","owner_name":"Aggarwal Gaurav","owner_url":"/insider/0001551965","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.15,"price_display":"2.15","price_state":"stated","total_value":21500.0,"total_display":"21,500.00","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-15","filed_date":"2016-01-19","scope":"insider"},{"id":8612869,"accession":"0001274644-15-000032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001274644-15-000032","line_url":"/filing/0001274644-15-000032#line-1","is_derivative":false,"issuer_cik":"0001274644","issuer_name":"Ocera Therapeutics, Inc.","issuer_ticker":"OCRX","issuer_name_source":null,"issuer_url":"/issuer/0001274644","owner_cik":"0001551965","owner_name":"Aggarwal Gaurav","owner_url":"/insider/0001551965","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":3.62,"price_display":"3.62","price_state":"stated","total_value":27150.0,"total_display":"27,150.00","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-06","filed_date":"2015-05-06","scope":"insider"},{"id":2778295,"accession":"0001123292-12-000793","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-12-000793","line_url":"/filing/0001123292-12-000793#line-1","is_derivative":false,"issuer_cik":"0001386858","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001386858","owner_cik":"0001551965","owner_name":"Aggarwal Gaurav","owner_url":"/insider/0001551965","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-31","filed_date":"2012-08-02","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001290149","name":"Sierra Oncology, Inc.","url":"/issuer/0001290149","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2022-01-31","last_seen":"2022-01-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001274644","name":"Ocera Therapeutics, Inc.","url":"/issuer/0001274644","role":"Officer (Chief Business Officer)","n_filings":2,"first_seen":"2015-05-06","last_seen":"2016-01-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001386858","name":"HYPERION THERAPEUTICS INC","url":"/issuer/0001386858","role":"Director","n_filings":1,"first_seen":"2012-08-02","last_seen":"2012-08-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001551965","retrieved_at":"2026-08-21T09:07:53+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}